Business
Biotech Industry's China Dilemma
The biotech industry is grappling with the decision to partner or compete with Chinese firms, leading to internal conflicts. This issue is impacting major players like Regeneron and other U.S. biotechs.
Coverage timeline — 2 articles
STAT News
China's ascent is forcing U.S. biotech companies and investors to pick a side: Is it an ally or an existential threat?
2026-05-18 08:30 UTC
STAT News
The question of whether to partner with Chinese firms — or see them as rivals — is tearing biotech apart, pitting peers and partners against one another
2026-05-18 13:11 UTC